Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$124.21
At close: Jun 27 EDT
$124.65
0.440.35%
Pre-Market: 7:41 AM EDT
Comments
Loading...
Repligen Analyst Ratings and Price Targets | NASDAQ:RGEN | Benzinga
Repligen Corp has a consensus price target of $181.07 based on the ratings of 18 analysts. The high is $220 issued by Keybanc on February 15, 2024. The low is $150 issued by Barclays on June 24, 2025. The 3 most-recent analyst ratings were released by Barclays, HC Wainwright & Co., and RBC Capital on June 24, 2025, May 5, 2025, and April 30, 2025, respectively. With an average price target of $173 between Barclays, HC Wainwright & Co., and RBC Capital, there's an implied 38.79% upside for Repligen Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HC Wainwright & Co.
RBC Capital
JP Morgan
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Repligen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2025 | Buy Now | 20.34% | Barclays | Luke Sergott52% | → $150 | Initiates | → Overweight | Get Alert |
| 05/05/2025 | Buy Now | 44.4% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2025 | Buy Now | 51.62% | RBC Capital | Conor McNamara36% | $202 → $189 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | 52.43% | JP Morgan | Rachel Vatnsdal65% | $200 → $190 | Maintains | Overweight | Get Alert |
| 04/16/2025 | Buy Now | 20.34% | Canaccord Genuity | Kyle Mikson41% | $170 → $150 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | 24.35% | Evercore ISI Group | Daniel Markowitz11% | → $155 | Initiates | → In-Line | Get Alert |
| 02/21/2025 | Buy Now | 64.46% | RBC Capital | Conor McNamara36% | $203 → $205 | Maintains | Outperform | Get Alert |
| 02/21/2025 | Buy Now | 60.45% | JP Morgan | Rachel Vatnsdal65% | $190 → $200 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 44.4% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 36.38% | Canaccord Genuity | Kyle Mikson41% | $165 → $170 | Maintains | Hold | Get Alert |
| 01/23/2025 | Buy Now | 44.4% | HC Wainwright & Co. | Raghuram Selvaraju44% | $240 → $180 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 32.37% | Canaccord Genuity | Kyle Mikson41% | → $165 | Initiates | → Hold | Get Alert |
| 11/14/2024 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Initiates | → Peer Perform | Get Alert |
| 09/26/2024 | Buy Now | 64.46% | RBC Capital | Conor McNamara36% | $205 → $205 | Reiterates | Outperform → Outperform | Get Alert |
| 08/27/2024 | Buy Now | 44.4% | Wells Fargo | Brandon Couillard69% | → $180 | Initiates | → Overweight | Get Alert |
| 08/05/2024 | Buy Now | — | Benchmark | Robert Wasserman52% | — | Reiterates | → Hold | Get Alert |
| 07/31/2024 | Buy Now | 60.45% | JP Morgan | Rachel Vatnsdal65% | $190 → $200 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | 48.42% | UBS | Elizabeth Garcia72% | $205 → $185 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 52.43% | RBC Capital | Conor McNamara36% | $190 → $190 | Reiterates | Outperform → Outperform | Get Alert |
| 07/30/2024 | Buy Now | 36.38% | Stephens & Co. | Jacob Johnson59% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | 24.35% | Deutsche Bank | Justin Bowers46% | $180 → $155 | Upgrade | Hold → Buy | Get Alert |
| 06/18/2024 | Buy Now | — | Guggenheim | Subbu Nambi51% | — | Initiates | → Neutral | Get Alert |
| 05/02/2024 | Buy Now | 60.45% | JP Morgan | Rachel Vatnsdal65% | $230 → $200 | Maintains | Overweight | Get Alert |
| 02/22/2024 | Buy Now | 66.06% | Stifel | Daniel Arias78% | $165 → $207 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 76.49% | Keybanc | Paul Knight54% | $210 → $220 | Maintains | Overweight | Get Alert |
| 12/20/2023 | Buy Now | 68.47% | JP Morgan | Rachel Vatnsdal65% | $170 → $210 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | — | Benchmark | Robert Wasserman52% | — | Downgrade | Buy → Hold | Get Alert |
| 11/02/2023 | Buy Now | 36.38% | UBS | Elizabeth Garcia72% | $210 → $170 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 32.37% | Stifel | Daniel Arias78% | $200 → $165 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 60.45% | RBC Capital | Conor McNamara36% | $207 → $200 | Maintains | Outperform | Get Alert |
| 11/01/2023 | Buy Now | 68.47% | Keybanc | Paul Knight54% | $240 → $210 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | 44.4% | JP Morgan | Rachel Vatnsdal65% | $200 → $180 | Maintains | Overweight | Get Alert |
| 09/08/2023 | Buy Now | 53.23% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | 53.23% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | Buy Now | 60.45% | Craig-Hallum | Matt Hewitt55% | $207 → $200 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 56.44% | RBC Capital | Conor McNamara36% | $157 → $195 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 60.45% | Stephens & Co. | Jacob Johnson59% | $180 → $200 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 48.42% | Wells Fargo | Timothy Daley53% | → $185 | Initiates | → Overweight | Get Alert |
| 07/06/2023 | Buy Now | 25.15% | RBC Capital | Conor McNamara36% | → $156 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/03/2023 | Buy Now | 25.95% | RBC Capital | Conor McNamara36% | $170 → $157 | Maintains | Sector Perform | Get Alert |
| 05/03/2023 | Buy Now | 68.47% | Stifel | Daniel Arias78% | $225 → $210 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 60.45% | Stephens & Co. | Jacob Johnson59% | $220 → $200 | Maintains | Overweight | Get Alert |
| 03/28/2023 | Buy Now | 84.52% | Benchmark | Robert Wasserman52% | → $230 | Initiates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | 92.54% | Keybanc | Paul Knight54% | $260 → $240 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 60.45% | SVB Leerink | Puneet Souda56% | $230 → $200 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 44.4% | Deutsche Bank | Justin Bowers46% | → $180 | Initiates | → Hold | Get Alert |
| 12/07/2022 | Buy Now | 52.43% | RBC Capital | Conor McNamara36% | → $190 | Initiates | → Sector Perform | Get Alert |
| 08/03/2022 | Buy Now | 120.62% | Stephens & Co. | Jacob Johnson59% | $220 → $275 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 100.56% | SVB Leerink | Puneet Souda56% | $220 → $250 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 108.58% | Keybanc | Paul Knight54% | $245 → $260 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | 70.88% | UBS | Elizabeth Garcia72% | → $213 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Repligen (RGEN) stock?
The latest price target for Repligen (NASDAQ:RGEN) was reported by Barclays on June 24, 2025. The analyst firm set a price target for $150.00 expecting RGEN to rise to within 12 months (a possible 20.34% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Repligen (RGEN)?
The latest analyst rating for Repligen (NASDAQ:RGEN) was provided by Barclays, and Repligen initiated their overweight rating.
When was the last upgrade for Repligen (RGEN)?
The last upgrade for Repligen Corp happened on June 26, 2024 when Deutsche Bank raised their price target to $155. Deutsche Bank previously had a hold for Repligen Corp.
When was the last downgrade for Repligen (RGEN)?
The last downgrade for Repligen Corp happened on December 4, 2023 when Benchmark changed their price target from N/A to N/A for Repligen Corp.
When is the next analyst rating going to be posted or updated for Repligen (RGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repligen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repligen was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.
Is the Analyst Rating Repligen (RGEN) correct?
While ratings are subjective and will change, the latest Repligen (RGEN) rating was a initiated with a price target of $0.00 to $150.00. The current price Repligen (RGEN) is trading at is $124.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
